Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway
Metrics: PDF 862 views | HTML 1142 views | ?
Xiaoyu Li1, Yi Liu2, Cuiping Zhang1, Qinghui Niu3, Hui Wang3, Cong Che1, Man Xie1, Bin Zhou4, Yonghong Xu1, Qi Zhang1, Jun Wu1, Zibin Tian1
1Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
2Department of Gastroenterology, Shanxian Central Hospital, Heze 274000, China
3Department of Infectious Diseases, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
4Department of Hepatobiliary Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, China
Zibin Tian, email: email@example.com
Keywords: Hippo-YAP pathway, PDAC, SJAMP, cell proliferation
Received: August 23, 2016 Accepted: January 04, 2017 Published: January 13, 2017
Previous studies have indicated that stiehopus japonieus acidic mucopolysaccharide (SJAMP) could inhibit the proliferation of pancreatic cancer cell SW1990. However, the mechanism remains unclear. In our study, YAP expression was identified by immunohistochemistry and quantitative Real-time PCR from 45 pairs of human pancreatic ductal adenocarcinoma (PDAC) tissues and their adjacent non-tumor samples. We found that the YAP expression was associated with the histological differentiation degree, and negatively correlated with pancreatic cancer patients’ survival. More YAP localization in nuclear and enhanced expression of YAP mRNA in pancreatic cancer tissue was found in comparison with in the normal tissue. These results identify YAP acts as an amazing regulator in the pathogenesis of pancreatic cancer. After affected by SJAMP, YAP and TEAD1 were down regulated, while MST1 and pYAP were upregulated gradually with the prolong of effect time. SJAMP also improved YAP phosphorylation, nuclear-to-cytoplasmic translocation and inactivation. After successfully knocked-down by YAP siRNA, the inhibition of proliferation of SJAMP to cancer cells was attenuated. Interestingly, we indicated a down-regulation of that TEAD with SJAMP 4 mg/ml, 8 mg/ml for 24 h and with 8 mg/ml SJAMP for 24 h, 48 h even after YAP silencing. That might mean that the SJAMP has other targets, not only YAP, to downregulate TEAD. We proposed a hypothesis that Hippo-YAP pathway involved in carcinogenesis of pancreatic cancer and in the inhibition effect of SJAMP to the proliferation of pancreatic cancer cell, although maybe not the sole signaling pathway.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.